25 related articles for article (PubMed ID: 38341408)
1. Correction to 'Autophagy mediates survival of pancreatic tumour-initiating cells in a hypoxic microenvironment'.
J Pathol; 2024 Jun; 263(2):270. PubMed ID: 38512138
[No Abstract] [Full Text] [Related]
2. Tetralol derivative NNC-55-0396 induces glioblastoma cell death by activating IRE1α, JNK1 and calcium signaling.
Visa A; Alza L; Cantí C; Herreros J
Biomed Pharmacother; 2022 May; 149():112881. PubMed ID: 35367758
[TBL] [Abstract][Full Text] [Related]
3. The genotypic and phenotypic impact of hypoxia microenvironment on glioblastoma cell lines.
Macharia LW; Muriithi W; Heming CP; Nyaga DK; Aran V; Mureithi MW; Ferrer VP; Pane A; Filho PN; Moura-Neto V
BMC Cancer; 2021 Nov; 21(1):1248. PubMed ID: 34798868
[TBL] [Abstract][Full Text] [Related]
4. The HIF1α/HIF2α-miR210-3p network regulates glioblastoma cell proliferation, dedifferentiation and chemoresistance through EGF under hypoxic conditions.
Wang P; Yan Q; Liao B; Zhao L; Xiong S; Wang J; Zou D; Pan J; Wu L; Deng Y; Wu N; Gong S
Cell Death Dis; 2020 Nov; 11(11):992. PubMed ID: 33208727
[TBL] [Abstract][Full Text] [Related]
5. T-Type Ca
Visa A; Sallán MC; Maiques O; Alza L; Talavera E; López-Ortega R; Santacana M; Herreros J; Cantí C
Cancer Res; 2019 Apr; 79(8):1857-1868. PubMed ID: 30755443
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a/Bad/Bax axis.
Ge X; Pan MH; Wang L; Li W; Jiang C; He J; Abouzid K; Liu LZ; Shi Z; Jiang BH
Cell Death Dis; 2018 Nov; 9(11):1128. PubMed ID: 30425242
[TBL] [Abstract][Full Text] [Related]
7. Tetralol derivative NNC-55-0396 targets hypoxic cells in the glioblastoma microenvironment: an organ-on-chip approach.
Bayona C; Alza L; Ranđelović T; Sallán MC; Visa A; Cantí C; Ochoa I; Oliván S; Herreros J
Cell Death Dis; 2024 Feb; 15(2):127. PubMed ID: 38341408
[TBL] [Abstract][Full Text] [Related]
8. Natural flavonoids alleviate glioblastoma multiforme by regulating long non-coding RNA.
Liu X; Xiao X; Han X; Yao L; Lan W
Biomed Pharmacother; 2023 May; 161():114477. PubMed ID: 36931030
[TBL] [Abstract][Full Text] [Related]
9. Transcription factors in glioblastoma - Molecular pathogenesis and clinical implications.
Papavassiliou KA; Papavassiliou AG
Biochim Biophys Acta Rev Cancer; 2022 Jan; 1877(1):188667. PubMed ID: 34894431
[TBL] [Abstract][Full Text] [Related]
10. Overview of Transforming Growth Factor β Superfamily Involvement in Glioblastoma Initiation and Progression.
Nana AW; Yang PM; Lin HY
Asian Pac J Cancer Prev; 2015; 16(16):6813-23. PubMed ID: 26514451
[TBL] [Abstract][Full Text] [Related]
11. The role of STAT3 in glioblastoma progression through dual influences on tumor cells and the immune microenvironment.
Chang N; Ahn SH; Kong DS; Lee HW; Nam DH
Mol Cell Endocrinol; 2017 Aug; 451():53-65. PubMed ID: 28089821
[TBL] [Abstract][Full Text] [Related]
12. Multidrug resistance in glioblastoma stem-like cells: Role of the hypoxic microenvironment and adenosine signaling.
Uribe D; Torres Á; Rocha JD; Niechi I; Oyarzún C; Sobrevia L; San Martín R; Quezada C
Mol Aspects Med; 2017 Jun; 55():140-151. PubMed ID: 28223127
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]